Gene · 4921
Papers2,653
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 2,653
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SMARCA2/BRM-Deficient Undifferentiated/Rhabdoid Carcinoma of Unknown Primary Site. | Case Rep Oncol | 2022 | 35431870 | PubTator, text mining | PubMed |
| Genomic Analysis of Tumors from Patients with Glioblastoma with Long-Term Response to Afatinib. | Onco Targets Ther | 2022 | 35422631 | PubTator, text mining | PubMed |
| Novel frameshift variant in the PCNT gene associated with Microcephalic Osteodysplastic Primordial Dwarfism (MOPD) Type II and small kidneys. | BMC Med Genomics | 2022 | 35422036 | PubTator, text mining | PubMed |
| Stromal Factors as a Target for Immunotherapy in Melanoma and Non-Melanoma Skin Cancers. | Int J Mol Sci | 2022 | 35409404 | PubTator, text mining | PubMed |
| Identification of Codon 146 KRAS Variants in Isolated Epidermal Nevus and Multiple Lesions in Oculoectodermal Syndrome: Confirmation of the Phenotypic Continuum of Mosaic RASopathies. | Int J Mol Sci | 2022 | 35409398 | PubTator, text mining | PubMed |
| Genetic Clonality as the Hallmark Driving Evolution of Non-Small Cell Lung Cancer. | Cancers (Basel) | 2022 | 35406585 | PubTator, text mining | PubMed |
| E-Cadherin-Deficient Cells Are Sensitive to the Multikinase Inhibitor Dasatinib. | Cancers (Basel) | 2022 | 35406381 | PubTator, text mining | PubMed |
| Clinicopathologic and molecular characteristics of EGFR-mutant lung adenocarcinomas that transform to small cell lung cancer after TKI therapy. | Transl Lung Cancer Res | 2022 | 35399568 | PubTator, text mining | PubMed |
| Anti-cancer peptide-based therapeutic strategies in solid tumors. | Cell Mol Biol Lett | 2022 | 35397496 | PubTator, text mining | PubMed |
| Physical and functional interactome atlas of human receptor tyrosine kinases. | EMBO Rep | 2022 | 35384245 | PubTator, text mining | PubMed |
| Endometrioid Cancer Associated With Endometriosis: From the Seed and Soil Theory to Clinical Practice. | Front Oncol | 2022 | 35359373 | PubTator, text mining | PubMed |
| A pilot study of genomic-guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high-risk neuroblastoma. | Cancer Rep (Hoboken) | 2022 | 35355452 | PubTator, text mining | PubMed |
| Evaluation of Early Biomarkers of Atherosclerosis Associated with Polychlorinated Biphenyl Exposure: An in Vitro and in Vivo Study. | Environ Health Perspect | 2022 | 35349355 | PubTator, text mining | PubMed |
| Transcriptome-wide N6-methyladenine methylation in granulosa cells of women with decreased ovarian reserve. | BMC Genomics | 2022 | 35346019 | PubTator, text mining | PubMed |
| Exploration of predictive biomarkers for postoperative recurrence of stage II/III colorectal cancer using genomic sequencing. | Cancer Med | 2022 | 35343095 | PubTator, text mining | PubMed |
| Bioinformatics Analysis of Differential Gene and MicroRNA Expression in Lung Adenocarcinoma: Genetic Effects on Patient Prognosis, as Indicated by the TCGA Database. | Cancer Inform | 2022 | 35342284 | PubTator, text mining | PubMed |
| Targeting ferroptosis as a vulnerability in cancer. | Nat Rev Cancer | 2022 | 35338310 | PubTator, text mining | PubMed |
| Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy. | J Hematol Oncol | 2022 | 35331296 | PubTator, text mining | PubMed |
| Correlation of KRAS G12C Mutation and High PD-L1 Expression with Clinical Outcome in NSCLC Patients Treated with Anti-PD1 Immunotherapy. | J Clin Med | 2022 | 35329953 | PubTator, text mining | PubMed |
| COL11A1-Driven Epithelial-Mesenchymal Transition and Stemness of Pancreatic Cancer Cells Induce Cell Migration and Invasion by Modulating the AKT/GSK-3β/Snail Pathway. | Biomolecules | 2022 | 35327583 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4921/papers?page=33